Vivos therapeutics announces positive results from 7-month multi-site pilot of its new provider-based marketing and distribution model

8 out of 10 newly diagnosed osa patients choose oral appliance therapy over cpap and preferred vivos' flagship care oral medical devices 5 to 1 over traditional oral appliances 8 out of 10 newly diagnosed osa patients choose oral appliance therapy over cpap and preferred vivos' flagship care oral medical devices 5 to 1 over traditional oral appliances
VVOS Ratings Summary
VVOS Quant Ranking